United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 259,046 | 413,794 | 284,258 | 322,230 | 343,550 |
| Marketable Securities | 308,534 | 346,698 | 409,645 | 394,612 | 353,041 |
| Receivables | 212,902 | 131,771 | 126,297 | 130,642 | 131,565 |
| Inventories | 58,033 | 51,717 | 47,758 | 49,617 | 44,713 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 14,554 |
| Other current assets | 43,093 | 46,288 | 46,424 | 35,641 | 5,013 |
| TOTAL | $881,608 | $990,268 | $914,382 | $932,742 | $903,583 |
| Non-Current Assets | |||||
| PPE Net | 477,534 | 474,410 | 464,950 | 449,942 | 447,893 |
| Investments And Advances | 280,887 | 389,533 | 448,134 | 327,295 | 203,484 |
| Other Non-Current Assets | 312,843 | 260,723 | 260,101 | 217,678 | 222,713 |
| TOTAL | $1,071,264 | $1,124,666 | $1,173,185 | $994,915 | $874,090 |
| Total Assets | $1,952,872 | $2,114,934 | $2,087,567 | $1,927,657 | $1,777,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 363,326 | 285,353 | 282,459 | 212,967 | 210,166 |
| Accounts payable and accrued liabilities | 112,246 | 104,015 | 92,244 | 97,510 | 9,377 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 81,727 |
| Other current liabilities | 183,501 | 269,167 | 312,971 | 158,432 | 110,955 |
| TOTAL | $659,073 | $658,535 | $687,674 | $468,909 | $412,225 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 119,894 | 140,852 | 140,619 | 198,548 | 200,025 |
| TOTAL | $119,894 | $140,852 | $140,619 | $198,548 | $200,025 |
| Total Liabilities | $778,967 | $799,387 | $828,293 | $667,457 | $612,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,269 | 48,176 | 50,477 | 50,227 | 49,924 |
| Common Shares | 638 | 633 | 630 | 628 | 625 |
| Retained earnings | 977,416 | 865,564 | 728,040 | 758,354 | 695,669 |
| Other shareholders' equity | -14,625 | -15,711 | -13,620 | -15,500 | -17,552 |
| TOTAL | $1,173,905 | $1,315,547 | $1,259,274 | $1,260,200 | $1,165,423 |
| Total Liabilities And Equity | $1,952,872 | $2,114,934 | $2,087,567 | $1,927,657 | $1,777,673 |